Press Room

Share

Harkin Amendment Would Restore Critical Funding for Cancer Research and Prevention Programs

March 13, 2013

WASHINGTON, D.C. March 13, 2013 The American Cancer Society Cancer Action Network (ACS CAN) is calling on senators to make cancer a top priority by voting to restore important federal funding for medical research and proven cancer prevention programs in the proposed FY2013 spending bill. An amendment to the spending bill to be offered by Sen. Tom Harkin (D-IA) would begin to reinstate a small amount of the cancer research and prevention funding that has been cut over the past few months, first with the fiscal cliff legislationŒæ and more recently with the sequester. Christopher W. Hansen, president of ACS CAN, the advocacy affiliate of the American Cancer Society, sent a letter to senators today encouraging them to maintain the urgency of the fight against cancer, which kills 1,500 people in America each day, by supporting the amendment. Federal cancer research and prevention funding saves lives, and promotes high technology growth and U.S. leadership in one of the world 's most important and competitive industries, Hansen wrote. We should view it as an investment in the nation 's future that supports and contributes to the fight against a disease that has ravaged the world 's population since the beginning of history. To view the full text of the letter, click here. Œæ ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit www.fightcancer.org. FOR MORE INFORMATION, CONTACT: Alissa Crispino or Steven Weiss American Cancer Society Cancer Action Network Phone: (202) 661-5772 or (202) 661-5711 Email: [email protected] or [email protected] #acscan #cancer #research #prevention #NIH #NCI #CDC

More Press Releases AboutCancer Research Funding

Related Press Releases

April 26, 2024

American Cancer Society Cancer Action Network Calls on U.S. Senate Candidates in Maryland to Make Cancer a Priority

The American Cancer Society Cancer Action Network (ACS CAN) called on U.S. Senate candidates in Maryland to clearly state their commitments to fighting cancer, and one of the candidates, Congressman David Trone, sat down with cancer survivors earlier today to discuss policies that alleviate the burden of cancer, a disease that continues to kill more than 1,600 Americans every day. The effort is part of ACS CAN’s national Cancer Votes program – the country’s leading voter education program for cancer-related issues and policies.

Read More
March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read more
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more